In 2008, In vivo treatment with therapies using cannabinoid receptors caused a significant reduction of tumor size in mice.
Background: This study, evaluated the expression of cannabinoid receptors CB1 and CB2 in non‐Hodgkin lymphomas.
You can read the full article here =>http://www.ncbi.nlm.nih.gov/pubmed/18546271